The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Vaxxinity, Inc. announced that UB-311, an anti-amyloid beta immunotherapeutic vaccine, has been granted Fast Track designation by the U.S. Food and ...
read more
Merck announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of microsatellite ...
read more
AstraZeneca announced plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation hub.
read more
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Camzyos™ (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules) ...
read more
Ultomiris (ravulizumab-cwvz) has been approved in the US for the treatment of adult patients with generalised myasthenia gravis (gMG) who are anti-...
read more
Prothena Corporation plc announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for PRX012, a potential best-in...
read more
Evoke Pharma, Inc. has been granted new drug product exclusivity by the (FDA for GIMOTI (metoclopramide) nasal spray.
read more
The University of Tokyo and Astellas Pharma Inc. have entered the second phase of their collaboration for co-creating innovative new medicines and ...
read more
AstraZeneca’s Biologics License Application (BLA) for tremelimumab has been accepted for Priority Review in the US, supporting the indication of a ...
read more
Merck announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending...
read more
Direct Biologics announced that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo,...
read more
Novavax, Inc. has initiated administration of the first booster doses of NVX-CoV2373, the company's protein-based COVID-19 vaccine, in the pediatric ...
read more
Detailed results from the PROVENT Phase III pre-exposure prophylaxis (prevention) trial showed that AstraZeneca’s Evusheld (tixagevimab and cilgavimab...
read more
Breckenridge Pharmaceutical, Inc. has launched Pencillamine Capsules, USP (generic for Cuprimine®).
read more
Novavax, Inc. announced initial results from the Phase 1/2 clinical trial of its COVID-Influenza Combination Vaccine (CIC). The CIC combines Novavax' ...
read more